A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors

Clinical trial NCT06239155 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06239155
Sponsor: Ascentawits Pharmaceuticals, Ltd
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Hepatocellular Carcinoma

Start date: 2019-09-03
Primary completion: 2025-11-30
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.